NCT06085937View on ClinicalTrials.gov

Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department

PHASE1RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
SuicideSuicidal IdeationDepression
Interventions
DRUG

Ketamine

Patients will receive 0.2mg/kg of IV ketamine

Trial Locations (2)

66101

NOT_YET_RECRUITING

University of Kansas Strawberry Hill Campus, Kansas City

66160

RECRUITING

University of Kansas Medical Center Emergency Department, Kansas City

All Listed Sponsors
lead

Lindsay Maguire, MD

OTHER